Zimmer Biomet Holdings
ZBH
88.49
-1.19
-1.33%
Zimmer Biomet Holdings
US · ZBH
#1040 by market cap
Listed 1970
88.49
-1.19
-1.33%
Live - 5344 symbols - heartbeat 554s ago
· 2026-10-07 20:02
After-hours
88.00
-0.55%
- Market cap
- 16.88B
- P/E (TTM)i
- 21.48
- P/Bi
- 1.34
- EPSi
- 3.55
- Div yieldi
- 1.08%
- 52W posi
- 36%
Reader sentiment
Are you bullish or bearish on ZBH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 7 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.1 percentage points.
Institutional ownership
- Held by institutions
- 106.40% -0.12pp
- Institutions
- 1,080 -7
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund91.93%
Hedge Fund6.17%
Public Company3.91%
Government Pension Fund1.86%
Sovereign Wealth Fund0.86%
Private Company0.76%
Insurance Company0.34%
Family Office/Trust0.25%
Individual/Insider0.18%
Top holders as of 2026-06-30
Dodge & Cox
12.65% · 24.12M sh
BlackRock
8.19% · 15.61M sh
Vanguard Capital Management, LLC
7.19% · 13.72M sh
Harris Associates L.P.
6.68% · 12.74M sh
Capital Research
6.53% · 12.45M sh
State Street Global Advisors
4.65% · 8.88M sh
Vanguard Portfolio Management, LLC
4.43% · 8.44M sh
Geode Capital Management, LLC
2.80% · 5.35M sh
T. Rowe Price Group, Inc.
2.52% · 4.80M sh
UBS Asset Management
2.21% · 4.22M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 41 buys · 9 sells
| Name | Role | Stake |
|---|---|---|
| Ivan Tornos | COO, President, CEO & Director | 0.04% |
| Suketu Upadhyay | CFO and Executive VP of Finance, Operations & Supply Chain | 0.04% |
| Chad Phipps | Senior Vice President | 0.03% |
| Wilfred van Zuilen | Group President of Europe, Middle East & Africa | 0.02% |
| Sang Yi | President of Asia Pacific | 0.01% |
| Mark Bezjak | President of Americas | 0.01% |
| Rachel Ellingson | Senior Vice President & Chief Strategy Officer | 0.01% |
| Lori Winkler | Chief Human Resources Officer | 0.01% |
| Paul Stellato | Chief Accounting Officer | 0.00% |
| Betsy Bernard | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Robert Hagemann | Independent Director | Other Derivative Acquisition | +306 | $89.85 |
| 2026-09-29 | Arthur Higgins | Independent Director | Other Derivative Acquisition | +306 | $89.85 |
| 2026-09-29 | Louis Shapiro | Director | Other Derivative Acquisition | +153 | $89.85 |
| 2026-09-29 | Maria Hilado | Independent Director | Other Derivative Acquisition | +375 | $89.85 |
| 2026-09-29 | Michael Farrell | Independent Director | Other Derivative Acquisition | +417 | $89.85 |
| 2026-09-29 | Devdatt Kurdikar | Director | Other Derivative Acquisition | +173 | $89.85 |
| 2026-09-29 | Sreelakshmi Kolli | Independent Director | Other Derivative Acquisition | +173 | $89.85 |
| 2026-09-10 | Kevin Thornal | Group President of Global Businesses & Americas | Open Market Disposition | -5,691 | $92.95 |
| 2026-09-03 | Chad Phipps | Senior Vice President | Open Market Disposition | -3,000 | $98.35 |
| 2026-08-02 | Chintan Desai | President Asia Pacific Region | Other Derivative Acquisition | +10,168 | -- |
| 2026-07-31 | Kevin Thornal | Group President of Global Businesses & Americas | Derivative Exercise and Sale | -4,266 | $92.68 |
| 2026-07-31 | Kevin Thornal | Group President of Global Businesses & Americas | Derivative Exercise and Retained | +5,691 | -- |
| 2026-07-15 | Suketu Upadhyay | CFO and Executive VP of Finance, Operations & Supply Chain | Intent to Sell (Form 144) | -7,668 | $92.86 |
| 2026-06-29 | Robert Hagemann | Independent Director | Other Derivative Acquisition | +317 | $86.65 |
| 2026-06-29 | Arthur Higgins | Independent Director | Other Derivative Acquisition | +317 | $86.65 |
| 2026-06-29 | Louis Shapiro | Director | Other Derivative Acquisition | +158 | $86.65 |
| 2026-06-29 | Maria Hilado | Independent Director | Other Derivative Acquisition | +389 | $86.65 |
| 2026-06-29 | Michael Farrell | Independent Director | Other Derivative Acquisition | +432 | $86.65 |
| 2026-06-29 | Devdatt Kurdikar | Director | Other Derivative Acquisition | +180 | $86.65 |
| 2026-06-29 | Sreelakshmi Kolli | Independent Director | Other Derivative Acquisition | +180 | $86.65 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 20:02:42 · For reference only, not investment advice and not tailored to your situation.